US Patent 9868951 Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
Patent 9868951 was granted and assigned to The Wistar Institute on January, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9868951 Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.